PAA 8.89% 24.5¢ pharmaust limited

The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-1368

  1. 568 Posts.
    lightbulb Created with Sketch. 94
    Interesting thoughts NZ!

    Have you personally discarded alternate funding methods other than a CR?

    I'm curious how you view the chances of ODD approval? From my reading, the benchmark doesn't seem all that high?

    MT did suggest that the survival data alone may support ODD approval. That was prior to the outstanding ALS-FRS results based on the statistical analysis?

 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
0.020(8.89%)
Mkt cap ! $96.99M
Open High Low Value Volume
22.5¢ 24.5¢ 22.5¢ $150.8K 649.5K

Buyers (Bids)

No. Vol. Price($)
2 30000 23.5¢
 

Sellers (Offers)

Price($) Vol. No.
24.5¢ 50607 2
View Market Depth
Last trade - 16.10pm 17/06/2024 (20 minute delay) ?
Last
24.0¢
  Change
0.020 ( 6.67 %)
Open High Low Volume
22.5¢ 24.0¢ 22.5¢ 231366
Last updated 15.56pm 17/06/2024 ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.